Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Accounting & Business Advisory Leader Clark Schaefer Hackett Chooses AI Networking with Nile
-
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
-
Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
-
Creative Realities Elevates Game Day with Innovative Digital Signage in Sports & Entertainment Venues
-
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
-
PlanSource Welcomes Jennifer Zador as General Counsel and Chief Compliance Officer
-
OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use
-
Beamr in Q2-2024: Enhancements to Beamr Cloud and Collaborations with Industry Giants
-
LeddarTech Enters Into Amendment to Credit Facility and Announces Receipt of Nasdaq Deficiency Notices
-
Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update
-
The National Minority Enterprise Development Week (MED Week) Deadline for Nominations Fast Approaching on August 15, 2024
-
ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology
-
Silvaco To Present at the Rosenblatt 4th Annual Technology Summit
-
European Wax Center Announces Appointment of Julia Hunter to Board Of Directors
-
Passage Bio to Participate in Upcoming Investor Conferences
-
GlobalFoundries Reports Second Quarter 2024 Financial Results
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Second-Quarter Results
-
Fuller Theological Seminary Announces the Launch of "The New Testament in Color"
-
Creative Realities Elevates Game Day with Innovative Digital Signage in Sports & Entertainment Venues
-
SimiTree Welcomes New Industry Experts Colleen Lazar and Brittney Lovely
-
George Medicines files New Drug Application with FDA for novel low dose triple combination for treatment of hypertension following successful international Phase III development program
-
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
-
AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
-
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
-
YieldMax™ ETFs Announces Monthly Distributions on MSTY (95.14%), TSLY (83.44%), CONY (75.83%), NVDY (64.52%), CRSH (61.10%) and Others
-
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
OLAPLEX Reports Second Quarter 2024 Results
-
TopBuild Reports Second Quarter Results
-
Unitil Reports Second Quarter Earnings
-
Ring Energy Provides Management Team Update
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
MIND CTI Reports Second Quarter 2024 Results
-
Form 8.3 - AXA INVESTMENT MANAGERS: Bellway plc
-
Man Group PLC : Form 8.3 - Keywords Studios plc
-
Man Group PLC : Form 8.3 - Darktrace plc
-
Man Group PLC : Form 8.3 - Crest Nicholson Holdings plc
-
Probe Gold Advances Permitting for Novador Project
-
Ransomware Groups Weaponize Stolen Data to Increase Pressure on Targets Who Refuse to Pay, Sophos Report Finds
-
Digihost Announces US$4 Million Private Placement
-
VPG Reports Fiscal 2024 Second Quarter Results
-
GXO Reports Second Quarter 2024 Results
-
Hut 8 Announces New Chief Financial Officer
-
Vivid Seats Delivers Strong Second Quarter Results
-
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results
-
Kvika banki hf.: Transaction in relation to a share buyback programme
-
Man Group PLC : Form 8.3 - Bellway plc
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
Man Group PLC : Form 8.3 - Barratt Developments plc
